Paychex, Inc. Form 10-Q Summary
Business Context and Reporting Period
Paychex provides integrated human capital management, payroll, HR, benefits, and insurance solutions primarily to small and midsized businesses in the United States and parts of Europe. The company reports one operating segment.
This filing covers the quarter and six months ended November 30, 2022, representing the second quarter and first six months of fiscal 2023. Comparisons are to the corresponding fiscal 2022 periods.
Key Financial Metrics
| Metric | Three Months Ended November 30, 2022 | Year-over-Year Change | Six Months Ended November 30, 2022 | Year-over-Year Change |
|---|---|---|---|---|
| Total revenue | $1,190.3 million | 7% | $2,396.5 million | 9% |
| Service revenue | $1,168.6 million | 7% | $2,356.9 million | 9% |
| Operating income | $472.3 million | 7% | $967.9 million | 10% |
| Net income | $360.3 million | 8% | $739.5 million | 11% |
| Diluted EPS | $0.99 | 9% | $2.04 | 11% |
| Operating margin | 39.7% | Flat | 40.4% | Up from 40.3% |
| Operating cash flow | Not separately reported | — | $685.9 million | Up from $555.4 million |
Management Solutions revenue was $895.3 million for the quarter and $1.8 billion year to date, increasing 8% and 10%, respectively. PEO and Insurance Solutions revenue was $273.3 million for the quarter and $556.1 million year to date, increasing 4% and 6%, respectively.
Interest on funds held for clients increased 54% to $21.7 million in the quarter and 39% to $39.6 million year to date, driven by higher average interest rates and invested balances. The effective tax rate was 24.2% for the quarter and 23.5% year to date.
Adjusted net income, a non-GAAP measure, was $359.4 million for the quarter and $731.3 million year to date. EBITDA was $518.6 million for the quarter and $1.1 billion year to date.
Cash, Debt, Liquidity, and Capital Allocation
- Cash and cash equivalents were $1.1 billion at November 30, 2022, compared with $370.0 million at May 31, 2022.
- Total cash, restricted cash, and equivalents were $1.6 billion at November 30, 2022, broadly comparable with $1.6 billion at May 31, 2022.
- Total short-term and long-term borrowings, net of debt issuance costs, were $808.0 million, including $797.9 million of long-term borrowings and $10.1 million of short-term borrowings.
- The company had approximately $2.0 billion available under committed credit facilities and was in compliance with applicable covenants. No additional overnight borrowings occurred under the facilities after November 30, 2022 through the filing date.
- Operating cash flow was $685.9 million for the six months. Investing activities provided $1.1 billion, primarily because of net sales and maturities of available-for-sale securities. Financing activities used $1.1 billion, including $569.3 million of dividends and a $468.7 million decrease in client fund obligations.
- Dividends paid increased 20% year over year to $569.3 million for the six months. The company had $327.1 million remaining under its $400 million share repurchase authorization, with no repurchases during the second quarter.
- Funds held for clients were $3.1 billion at November 30, 2022, while client fund obligations were $3.4 billion.
Material Changes Versus the Prior Comparable Period
- Revenue growth was led by client and employee growth, price realization, higher product attachment, demand for HR Solutions, retirement and time-and-attendance offerings, and continued demand for HCM ancillary services.
- Expense growth was 7% for the quarter and 9% year to date. Compensation-related expenses increased 12% in both periods due to higher headcount and wage rates.
- Revenue growth outpaced expense growth, increasing operating income by 7% for the quarter and 10% year to date while maintaining approximately 40% operating margins.
- Corporate investment income improved substantially as interest income increased to $10.1 million for the quarter and $15.5 million year to date, compared with $0.4 million and $0.6 million, respectively, in the prior-year periods.
- Net unrealized losses on available-for-sale securities increased to $217.8 million at November 30, 2022 from $136.3 million at May 31, 2022, primarily reflecting higher interest rates. Management concluded the losses were not credit-related and did not record a credit-loss allowance.
- Average combined funds held for clients and corporate investments increased 5% for the quarter and 6% year to date, while the combined average interest rate earned increased to 2.4% and 2.0%, respectively, from 1.1% in both prior-year periods.
Outlook, Commentary, Risks, and Unusual Items
Management stated that cash, restricted cash, corporate investments, projected operating cash flows, and available financing are expected to support operations, capital purchases, share repurchases, and dividends for the foreseeable future. The company expects its total investment portfolio to average approximately $6.0 billion for fiscal 2023, with approximately half in short-term securities and variable-rate demand notes and half in available-for-sale securities.
Management identified a sensitivity of approximately $4.5 million to $5.0 million of after-tax annual earnings for a 25-basis-point change in short-term interest rates under normal conditions. A hypothetical 25-basis-point increase in longer-term rates would reduce the fair value of the available-for-sale portfolio by approximately $20 million to $25 million, with the effect recorded in stockholders’ equity unless credit impairment occurs.
- Key risks include cybersecurity and data privacy breaches, technology defects or disruption, third-party service-provider failures, business-continuity failures, regulatory changes, macroeconomic and inflationary pressures, labor-market conditions, and impacts on small and midsized business clients.
- PEO-related risks include health and workers’ compensation claim trends, insurance rates, co-employment obligations, and changes in actuarial estimates. The company’s maximum individual liability under certain health insurance arrangements was $0.5 million, and aggregate workers’ compensation liability was subject to stated limits.
- The company had $141.5 million of standby letters of credit supporting certain insurance commitments; no amounts were outstanding.
- Outstanding capital-asset purchase commitments were approximately $10.4 million. The company had maximum commitments of $30.0 million to venture capital funds and had contributed approximately $20.9 million as of November 30, 2022.
- Management believes pending legal matters will not materially affect financial position or results, but acknowledges that litigation outcomes are inherently uncertain.
- The filing does not provide a specific consolidated revenue or earnings-per-share forecast for fiscal 2023.
Important Facts for Investors to Verify
- Whether service-revenue growth and operating margins remain resilient as compensation costs, inflation, and client conditions change.
- The effect of further interest-rate movements on client-fund interest income, corporate investment income, and accumulated other comprehensive loss.
- The liquidity and valuation implications of the $217.8 million unrealized loss on available-for-sale securities and management’s ability to hold those securities to recovery or maturity.
- Future changes in client fund obligations and the timing of payroll-tax and employee remittances, which can materially affect reported cash flows.
- PEO workers’ compensation and health-insurance claims development, including potential reserve adjustments.
- Continuation of dividend payments and any future share repurchases in light of operating cash flow and capital requirements.
- Compliance with credit-facility and long-term-debt covenants, including refinancing or maturity considerations for the $800 million of fixed-rate Senior Notes.